Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
BURU compared with LIMN: revenue, margins and what each company keeps, and the suppliers and customers both name
BURU
Nuburu, Inc.
Change
Mkt cap
Revenue
Revenue
LIMN
Liminatus Pharma, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
BURU
Nuburu, Inc.
vs
LIMN
Liminatus Pharma, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
BURU
Report
implied
realized
× implied
Nov 10 '23
—
▼
−44.03%
—
Aug 11 '23
—
▼
−21.69%
—
May 12 '23
—
▼
−11.46%
—
Mar 9 '23
—
▼
−9.01%
—
LIMN
No earnings history for LIMN.
= implied
BURU realized, solid
LIMN realized, hatched
One scale, both sides: full bar = 45%
× = |realized| ÷ implied
Source: market data
BURU
Nuburu, Inc.
Change
0.25
▼
−0.48%
· post 0.25
Mkt cap
$1.3M
Revenue
$524,927
Q2 FY26
LIMN
Liminatus Pharma, Inc.
Change
2.92
▲
+15.69%
· post 2.74
Closed
Nov 3 '26
Mkt cap
$2.4M
Revenue
—
vs
Compare
Closed
Nov 3 '26
BURU
Nuburu, Inc.
vs
LIMN
Liminatus Pharma, Inc.
0.25
▼
−0.48%
post 0.25
Price
2.92
▲
+15.69%
post 2.74
$1.3M
Mkt cap
$2.4M
Q2 FY26
$524,927
Revenue
—
Change
Change
BURU
0.25
▼
−0.48%
vs
LIMN
2.92
▲
+15.69%
Closed
Nov 3 '26